Description

Currently, TLGY Acquisition Corporation does not engage in significant operational activities. The company's primary objective is to execute a business combination, which may include a merger, a capital stock exchange, an asset acquisition, a stock purchase, a reorganization, or a similar transaction, involving one or more enterprises. It aims to identify potential targets globally within the biopharmaceutical or technology-enabled direct-to-consumer (B2C) industries. Established in 2021, the entity maintains its corporate domicile in Wilmington, Delaware.